These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2892144)

  • 1. Smoking habits and antihypertensive treatment.
    Heyden S; Schneider KA; Fodor JG
    Nephron; 1987; 47 Suppl 1():99-103. PubMed ID: 2892144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smoking, antihypertensive treatment benefit, and comprehensive antihypertensive treatment approach: some thoughts on the results of the International Prospective Primary Prevention Study in Hypertension.
    Bolli P; Bühler FR; McKenzie JK
    J Cardiovasc Pharmacol; 1990; 16 Suppl 7():S77-80. PubMed ID: 1708033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of the long-term controlled trials of usefulness of therapy for systemic hypertension.
    Gifford RW
    Am J Cardiol; 1989 Jan; 63(4):8B-16B. PubMed ID: 2563189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of antihypertensive drug treatment on mortality in the presence of resting electrocardiographic abnormalities at baseline: the HDFP experience. The Hypertension Detection and Follow-up Program Cooperative Research Group.
    Circulation; 1984 Dec; 70(6):996-1003. PubMed ID: 6388901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between antihypertensive agents, serum lipids and cigarette smoking in high risk hypertensive patients.
    Plouin PF
    J Hum Hypertens; 1989 Dec; 3 Suppl 2():49-53; discussion 53-4. PubMed ID: 2575176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-blockers vs. thiazides in the treatment of hypertension: a review of the experience of the large national trials.
    Miall WE
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S58-63. PubMed ID: 11527138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Beta-Blockers in the Treatment of Hypertension.
    Cruickshank JM
    Adv Exp Med Biol; 2017; 956():149-166. PubMed ID: 27957711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.
    Curb JD; Pressel SL; Cutler JA; Savage PJ; Applegate WB; Black H; Camel G; Davis BR; Frost PH; Gonzalez N; Guthrie G; Oberman A; Rutan GH; Stamler J
    JAMA; 1996 Dec; 276(23):1886-92. PubMed ID: 8968014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary prevention with beta-blockade in patients with hypertension: review of results and clinical implications.
    Wikstrand J
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S64-75. PubMed ID: 11527139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
    Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
    JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term safety of antihypertensive therapy.
    Grossman E; Messerli FH
    Prog Cardiovasc Dis; 2006; 49(1):16-25. PubMed ID: 16867847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure to reduce cholesterol as explanation for the limited efficacy of antihypertensive treatment in the reduction of CHD. Examination of the evidence from six hypertension intervention trials.
    Heyden S; Schneider KA; Fodor GJ
    Klin Wochenschr; 1987 Sep; 65(17):828-32. PubMed ID: 3309458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cardiac protection and antihypertensive therapy: facts and theories].
    Verdecchia P
    Minerva Med; 1986 Jun; 77(26):1259-70. PubMed ID: 3523304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of the primary prevention trials against coronary heart disease.
    Kannel WB
    J Hypertens Suppl; 1990 Dec; 8(7):S245-50. PubMed ID: 1982770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.
    Psaty BM; Lumley T; Furberg CD; Schellenbaum G; Pahor M; Alderman MH; Weiss NS
    JAMA; 2003 May; 289(19):2534-44. PubMed ID: 12759325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-blockers and primary cardioprotection in hypertension.
    Fogari R; Zoppi A
    Drugs Exp Clin Res; 1990; 16(3):113-22. PubMed ID: 1974838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The case for beta-blockers as first-line antihypertensive therapy.
    Cruickshank JM
    J Hypertens Suppl; 1992 Jun; 10(3):S21-7. PubMed ID: 1353111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased coronary heart disease in hypertensive smokers. Mortality results from the MAPHY study.
    Tuomilehto J; Wikstrand J; Olsson G; Elmfeldt D; Warnold I; Barber H; Eliasson K; Jastrup B; Karatzas N; Leer J
    Hypertension; 1989 Jun; 13(6 Pt 2):773-80. PubMed ID: 2737719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recent intervention studies with antihypertensive drugs and their influence on guidelines].
    Rahn KH
    Med Klin (Munich); 2003 Dec; 98(12):771-5. PubMed ID: 14685679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Do beta-blockers prevent coronary events in hypertensive patients?].
    Diévart F; Ragot S; Julien J; Herpin D
    Arch Mal Coeur Vaiss; 2005 Sep; 98(9):881-8. PubMed ID: 16231574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.